Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer
Sokolowski, Kevin M, Koprowski, Steven, Kunnimalaiyaan, Selvi, Balamurugan, Mariappan, Gamblin, T Clark, Kunnimalaiyaan, Muthusamy
Published in Anti-cancer agents in medicinal chemistry (01.01.2016)
Published in Anti-cancer agents in medicinal chemistry (01.01.2016)
Get more information
Journal Article
Role of Akt inhibition on Notch1 expression in hepatocellular carcinoma: potential role for dual targeted therapy
Sokolowski, Kevin M., M.D, Balamurugan, Mariappan, Ph.D, Kunnimalaiyaan, Selvi, M.S, Wilson, Jacob, B.S, Gamblin, Thomas Clark, M.D., M.S., M.B.A., F.A.C.S, Kunnimalaiyaan, Muthusamy, Ph.D
Published in The American journal of surgery (01.04.2016)
Published in The American journal of surgery (01.04.2016)
Get full text
Journal Article
Phase 3 open-label, randomized, controlled study of disitamab vedotin with pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2 (DV-001)
Galsky, Matt D., Grande, Enrique, Necchi, Andrea, Koontz, Michael Zach, Iyer, Gopa, Campbell, Matthew T, Drakaki, Alexandra, Loriot, Yohann, Sokolowski, Kevin M., Zhang, Wei, Powles, Thomas
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma
Koprowski, Steven, BS, Sokolowski, Kevin, MD, Kunnimalaiyaan, Selvi, MS, Gamblin, T. Clark, MD, MS, Kunnimalaiyaan, Muthusamy, PhD
Published in The Journal of surgical research (01.10.2015)
Published in The Journal of surgical research (01.10.2015)
Get full text
Journal Article